Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

BACKGROUND: Mixed phenotype acute leukemia (MPAL) is a rare leukemia and is regarded as a high-risk entity with a poor prognosis. Induction therapy of an acute lymphoblastic leukemia type or hybrid regimen and hematopoietic stem cell transplantation has been recommended for MPAL. However, the optima...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng-Yun, Lin, Zhi-Hong, Hu, Ming-Ming, Kang, Li-Qing, Wu, Xiao-xia, Chen, Qi-wei, Kong, Xin, Zhang, Jian, Qiu, Hui-Ying, Wu, De-Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457525/
https://www.ncbi.nlm.nih.gov/pubmed/32874588
http://dx.doi.org/10.1186/s40364-020-00216-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457525/
https://www.ncbi.nlm.nih.gov/pubmed/32874588
http://dx.doi.org/10.1186/s40364-020-00216-1

Ejemplares similares